,0
symbol,AMRS
price,2.22
beta,0.67222
volAvg,2933093
mktCap,531048448
lastDiv,0.0
range,1.4-6.07
changes,0.18
companyName,Amyris Inc
currency,USD
cik,0001365916
isin,US03236M2008
cusip,03236M200
exchange,Nasdaq Global Select
exchangeShortName,NASDAQ
industry,Specialty Chemicals
website,https://www.amyris.com/
description,"Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 503 full-time employees. The firm is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. Its biotechnology platform and industrial fermentation process replace existing complex and expensive manufacturing processes. The Companyâ€™s platform is used to design, build, optimize and upscale strains producing eight distinct molecules at commercial volumes, leading to more than 15 commercial ingredients."
ceo,Mr. John Melo
sector,Basic Materials
country,US
fullTimeEmployees,561
phone,15104500761
address,5885 Hollis St Ste 100
city,Emeryville
state,CALIFORNIA
zip,94608
dcfDiff,-2574.7
dcf,2.74296
image,https://financialmodelingprep.com/image-stock/AMRS.png
ipoDate,2010-09-28
defaultImage,False
